Technical Analysis for ITRM - Iterum Therapeutics plc
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 1.60 | 3.23% | 0.05 |
ITRM closed up 3.23 percent on Wednesday, May 8, 2024, on 12 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 10
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
MACD Bullish Centerline Cross | Bullish | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Inside Day | Range Contraction | 0.00% | |
Fell Below 20 DMA | Bearish | 3.23% | |
MACD Bearish Centerline Cross | Bearish | 3.23% | |
Shooting Star Candlestick | Bearish | 3.23% | |
Bollinger Band Squeeze | Range Contraction | 3.23% | |
Calm After Storm | Range Contraction | 3.23% |
Alert | Time |
---|---|
Possible NR7 | about 15 hours ago |
Possible Inside Day | about 15 hours ago |
Up 5% | about 18 hours ago |
60 Minute Opening Range Breakout | about 18 hours ago |
Rose Above 10 DMA | about 18 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/10/2024
Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Stage Pharmaceutical
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Stage Pharmaceutical
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.5 |
52 Week Low | 0.622 |
Average Volume | 170,420 |
200-Day Moving Average | 1.32 |
50-Day Moving Average | 1.55 |
20-Day Moving Average | 1.55 |
10-Day Moving Average | 1.58 |
Average True Range | 0.12 |
RSI (14) | 52.38 |
ADX | 15.83 |
+DI | 15.12 |
-DI | 12.23 |
Chandelier Exit (Long, 3 ATRs) | 1.39 |
Chandelier Exit (Short, 3 ATRs) | 1.79 |
Upper Bollinger Bands | 1.68 |
Lower Bollinger Band | 1.43 |
Percent B (%b) | 0.69 |
BandWidth | 16.29 |
MACD Line | 0.00 |
MACD Signal Line | 0.00 |
MACD Histogram | 0.0026 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.72 | ||||
Resistance 3 (R3) | 1.72 | 1.68 | 1.70 | ||
Resistance 2 (R2) | 1.68 | 1.65 | 1.68 | 1.69 | |
Resistance 1 (R1) | 1.64 | 1.63 | 1.66 | 1.64 | 1.68 |
Pivot Point | 1.60 | 1.60 | 1.61 | 1.60 | 1.60 |
Support 1 (S1) | 1.56 | 1.57 | 1.58 | 1.56 | 1.52 |
Support 2 (S2) | 1.52 | 1.55 | 1.52 | 1.51 | |
Support 3 (S3) | 1.48 | 1.52 | 1.50 | ||
Support 4 (S4) | 1.48 |